A detailed history of Wealth Management Nebraska transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealth Management Nebraska holds 359 shares of LLY stock, worth $228,043. This represents 0.04% of its overall portfolio holdings.

Number of Shares
359
Previous 359 -0.0%
Holding current value
$228,043
Previous $297 Million 6.11%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$725.72 - $929.72 $69,669 - $89,253
96 Added 36.5%
359 $297 Million
Q4 2024

Feb 03, 2025

BUY
$727.2 - $932.06 $191,253 - $245,131
263 New
263 $203 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $604B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wealth Management Nebraska Portfolio

Follow Wealth Management Nebraska and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Management Nebraska, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Management Nebraska with notifications on news.